An industry leader with more than 30 years of experience, Lisa is a senior drug development, clinical and commercial expert. Lisa has successfully led programs across the entire product life cycle, including in medical affairs, clinical development, product development, portfolio planning and new product strategy for organizations from small biotechs to large pharmaceutical companies, including as the Global Dermatology Portfolio Leader, for Merck, head of Global Commercial Pharma Centers of Excellence and head of Early Pipeline Commercial Strategy for GSK, and the head of New Product Strategy for Akcea Therapeutics and Ionis Pharmaceuticals. Lisa is a board director at Assembly Bio and Tracon Pharma, and is the board chair of Young People in Recovery.
Lisa received her B.S. and M.D. degrees from Howard University, with further post-doctoral training in Internal Medicine, Clinical Pharmacology and Pharmaceutical Medicine.